SUMMARY A group of 54 patients with primary retinitis pigmentosa were studied and the following findings are described: response of lymphocytes to stimulation by phytohaemagglutinin (PHA); response of lymphocytes to stimulation by xenogenic retinal extract; distribution of T and T-active lymphoid populations; total suppressor activity induced by concanavalin-A (con-A). The results obtained showed a reduction in the response to PHA (p<005), a positive response of 26/45 (p<O-OO1) to stimulation by retinal extract, a reduction in the T and T-active lymphoid populations (p<O0O1), (p<O0O1), and a diminished total suppressor activity induced by con-A (p<OO1). This alteration of immune cellular responses and the diminished suppressor activity in the group of patients, in comparison with a control group of healthy subjects, seems to indicate the existence of an immune process of disregulation (autoimmunity?) in the pathology of primary retinitis pigmentosa.
The term 'primary retinitis pigmentosa' (PRP) coined more than 60 years ago by Collins ' denotes what we know today to be a genetically determined ocular alteration affecting approximately 0-5% of the world population.2 Its pathogenesis is as little known now as it was when the disease was first described. Rahi wrote recently: The degeneration of the pigment epithelium and photoreceptors of the retina, which is the hallmark of primary retinitis pigmentosa (PRP), is still without a satisfactory explanation.... For want of a better explanation an autoimmune hypothesis has been proposed, but the evidence is largely indirect and not entirely persuasive. 3 So far as indirect evidence is concerned we may cite the description of autoantigens located in the photoreceptors of guinea-pigs4 and characterised as soluble (S) and insoluble or particulate (P). These can produce P retinal antigen, antibodies, but not delayed response or ocular dystrophies, and, soluble retinal (S), antibodies, delayed response, and disease when injected into homologous animals.4 Rahi3 has demonstrated the antigenicity of the photoreceptors of bovine retina in rats and rabbits.
Phylogenetically closer are the observations of Study of the total suppressor activity induced by con-A. 2 ml of lymphocyte suspension (1 x 106 cells/ml) with 30 ,ug con-A/i x 10' cells (suppressor cells) and 2 ml only in culture medium (control cells) were incubated for 24 hours at 37°C in 5% Co2. of the control group by the Mann-Whitney U test and Student's t test. For the study of sensitisation to the RE the x2 test was used.
Results Fig. 1 shows the mean values and the deviations of the response indexes (RIs) of the 100 controls to the stimulation with 5 and 10 ,ug/ml of PHA: 69±35 and 76±31. However, the RIs of the 54 patients with PRP were 55+±32 and 59±32. There was a statistically significant difference (p<005) in the lowest RI registered in comparison with the values of the control group. Fig. 2 shows the positive and negative RIs of the 45 patients with PRP (the study was not carried out on 9 patients) when the lymphocytes were stimulated by 10 ,ug/ml of RE. An RI of 2 or higher was considered positive (26 positive responses and 19 negative responses to RE). In the control group, however, of the 21 subjects studied only 2 obtained an RI of 2 or higher (positive), the remaining 19 being negative (x2=13-99. p<O-OOl). (504± 10-1), (p<001) . As in the case of the T-active population (25± 13-9 in controls and 22-8±6-2 in patients) there was a statistically significant difference (p<001).
Finally, Fig. 4 shows the mean values and deviations of total suppressor activity induced by con-A. In the control group it was 34±13-9 and in the group of patients with PRP 13-1±23-2 (p<001). and its localisation in the layer of the photoreceptor cells14 have led some authors to consider the hypothesis of a possible relationship (so far as the autoimmune pathogenesis is concerned) between these and other experimental models and some human retinopathies. * This hypothesis was reaffirmed some years later in the conclusion of an immunological and immunogenetic study in man" which declared that the retina should be included in immunopathology. PRP could be included in the same group.
So far as the number of T-active lymphocytes are concerned Rocha and Antunes" found in a normal population 26+3 5, while the mean and deviations in patients with PRP were 22-2±8-1; whereas we obtained the following values: 25±13-9 in the control group and 22-8±6-2; (p<0-01) in the patient group. However, the number of controls and patients in the study by the Rocha and Antunes was unstated. A direct comparison of the numbers of T lymphocytes cannot be made since Rocha and Antunes'°did not determine it. They studied B instead of the T lymphocytes. There was no significant variation between healthy subjects and patients with PRP when studying the B population.
In our case the number of T lymphocytes was also lower in the group of patients with PRP than in the control group. There was a statistically significant control group (34±13-9), (p<OO1). The fall in the suppressor activity is described in other classic autoimmune processes such as the SLE"9 and juvenile rheumatoid arthritis,20 where the loss of the 'normal' level of suppression will result in the presence of autoantibodies and the nonfunctioning of the immunological regulation network.
The discovery of altered immune cellular response together with the reduction in suppressor activity in PRP seem to indicate the existence, at least with our methods of a process of immunological disregulation in this disease. And this may have some relevance if, as Leopold2' states, some ocular disorders in particular individuals might benefit from measures that increase the competence of the immune mechanism where it is low or absent and reduce it in others where cellular immunity might be harmful. 
